BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 22262361)

  • 1. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands: report of a case and review of the literature.
    Parks A; Branch KD; Metcalf J; Underwood P; Young J
    Am J Dermatopathol; 2012 Feb; 34(1):104-9. PubMed ID: 22262361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hidradenoma papilliferum with mixed histopathologic features of syringocystadenoma papilliferum and anogenital mammary-like glands.
    Nishie W; Sawamura D; Mayuzumi M; Takahashi S; Shimizu H
    J Cutan Pathol; 2004 Sep; 31(8):561-4. PubMed ID: 15268713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidradenoma papilliferum of the upper eyelid arising from the apocrine gland of Moll.
    Netland PA; Townsend DJ; Albert DM; Jakobiec FA
    Ophthalmology; 1990 Dec; 97(12):1593-8. PubMed ID: 1965020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hidradenoma papilliferum of the vulva in association with an anogenital mammary-like gland.
    Kurashige Y; Kishida K; Kurashige K; Minemura T; Nagatani T
    J Dermatol; 2014 May; 41(5):411-3. PubMed ID: 24617304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anatomoclinical and immunohistochemical study of hidradenoma papilliferum, a tumor deriving from anogenital mammary-like glands].
    Blind A; Weingertner N; Cribier B
    Ann Dermatol Venereol; 2019 Sep; 146(8-9):528-536. PubMed ID: 31285043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital papillated apocrine cystadenoma: a mixed form of hidrocystoma, hidradenoma papilliferum, and syringocystadenoma papilliferum.
    Schewach-Millet M; Trau H
    J Am Acad Dermatol; 1984 Aug; 11(2 Pt 2):374-6. PubMed ID: 6090513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubular apocrine adenoma in association with syringocystadenoma papilliferum.
    Aktepe F; Demir Y; Dilek FH
    Dermatol Online J; 2003 Feb; 9(1):7. PubMed ID: 12639465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical apocrine proliferation involving anogenital mammary-like glands of the perianal region.
    Charfi S; Sevestre H; Dumont F; Regimbeau JM; Chatelain D
    J Cutan Pathol; 2009 Oct; 36 Suppl 1():52-5. PubMed ID: 19775395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case of sebaceoma with extensive apocrine differentiation.
    Tanahashi J; Kashima K; Daa T; Kondoh Y; Yada N; Kuratomi E; Yokoyama S
    Am J Dermatopathol; 2008 Aug; 30(4):408-11. PubMed ID: 18645320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Syringocystadenoma papilliferum: a rare breast tumor in a young boy.
    Vaos G; Pierrakou P
    Pediatr Dev Pathol; 2006; 9(5):381-3. PubMed ID: 16953682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vulvar hidradenoma papilliferum (HP) is located on the sites of mammary-like anogenital glands (MLAGs): Analysis of the photographs of 52 tumors.
    El-Khoury J; Renald MH; Plantier F; Avril MF; Moyal-Barracco M
    J Am Acad Dermatol; 2016 Aug; 75(2):380-4. PubMed ID: 26944596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical fibroxanthoma arising in an area of syringocystadenoma papilliferum associated with nevus sebaceus: positivity of the atypical fibroxanthoma component for CD31.
    Tronnier M; Vogelbruch M
    J Cutan Pathol; 2007 Dec; 34 Suppl 1():58-63. PubMed ID: 17997741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma in situ arising in a tubulopapillary apocrine hidradenoma of the peri-anal region.
    Obaidat NA; Awamleh AA; Ghazarian DM
    Eur J Dermatol; 2006; 16(5):576-8. PubMed ID: 17101482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic hidradenoma papilliferum: a case report and review of the literature.
    Vang R; Cohen PR
    J Am Acad Dermatol; 1999 Jul; 41(1):115-8. PubMed ID: 10411423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syringocystadenoma papilliferum with sebaceous differentiation in an intradermal tubular apocrine component. Report of a case.
    Vazmitel M; Michal M; Mukensnabl P; Kazakov DV
    Am J Dermatopathol; 2008 Feb; 30(1):51-3. PubMed ID: 18212545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast.
    Tramm T; Kim JY; Tavassoli FA
    Am J Surg Pathol; 2011 Feb; 35(2):202-11. PubMed ID: 21263240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pure apocrine nevus: a report of 4 cases.
    Cordero SC; Royer MC; Rush WL; Hallman JR; Lupton GP
    Am J Dermatopathol; 2012 May; 34(3):305-9. PubMed ID: 22317889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-anogenital (ectopic) hidradenoma papilliferum with sebaceous differentiation: a case report and review of reported cases.
    Minami S; Sadanobu N; Ito T; Natsuaki M; Yamanishi K
    J Dermatol; 2006 Apr; 33(4):256-9. PubMed ID: 16674789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hidradenoma papilliferum with a ductal carcinoma in situ component: case report and review of the literature.
    Vazmitel M; Spagnolo DV; Nemcova J; Michal M; Kazakov DV
    Am J Dermatopathol; 2008 Aug; 30(4):392-4. PubMed ID: 18645314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Squamous cell apocrine hidradenoma.
    Angulo J; Jaqueti G; Kutzner H; Requena L
    J Cutan Pathol; 2007 Oct; 34(10):801-3. PubMed ID: 17880588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.